These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Confusion, dysphasia, and asterixis following metrizamide myelography. Smith MS; Laguna JF Can J Neurol Sci; 1980 Nov; 7(4):309-11. PubMed ID: 7214247 [TBL] [Abstract][Full Text] [Related]
4. Asterixis and encephalopathy following metrizamide myelography: investigations into possible mechanisms and review of the literature. Bertoni JM; Schwartzman RJ; Van Horn G; Partin J Ann Neurol; 1981 Apr; 9(4):366-70. PubMed ID: 7224601 [TBL] [Abstract][Full Text] [Related]
5. Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumbar myelography. Richert S; Sartor K; Holl B Neuroradiology; 1979 Oct; 18(4):177-84. PubMed ID: 530428 [TBL] [Abstract][Full Text] [Related]
6. Intracranial metrizamide following myelography. Llewellyn G; Gaudet L; Quartey GR; Campbell DR J Can Assoc Radiol; 1984 Sep; 35(3):259-61. PubMed ID: 6501381 [TBL] [Abstract][Full Text] [Related]
7. Absence status epilepticus with computed tomographic brain changes following metrizamide myelography. Obeid T; Yaqub B; Panayiotopoulos C; al-Jasser S; Shabaan A; Hawass NE Ann Neurol; 1988 Oct; 24(4):582-4. PubMed ID: 3239959 [TBL] [Abstract][Full Text] [Related]
8. Mental disorders after myelography with metrizamide and other water-soluble contrast media. Schmidt RC Neuroradiology; 1980 Apr; 19(3):153-7. PubMed ID: 7383336 [TBL] [Abstract][Full Text] [Related]
9. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography. Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of metrizamide for neuroradiology in chilren. Swick HM; Sty JR; Haughton VM Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277 [TBL] [Abstract][Full Text] [Related]
14. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide. Skalpe IO Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906 [TBL] [Abstract][Full Text] [Related]
15. Transient areflexia following thoraco-lumbar myelography with metrizamide. Report of a case. Buruma OJ; Hekster RE Acta Radiol Suppl; 1977; 355():371-2. PubMed ID: 299681 [TBL] [Abstract][Full Text] [Related]
16. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial. Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981 [TBL] [Abstract][Full Text] [Related]
17. Generalized motor seizure following metrizamide cisternography. Saltiel E; Adelman DC; Ellis JC; Young WI Drug Intell Clin Pharm; 1984 Nov; 18(11):894-6. PubMed ID: 6437782 [TBL] [Abstract][Full Text] [Related]
18. The incidence of headache following various techniques of metrizamide myelography. Rolfe EB; Maguire PD Br J Radiol; 1980 Sep; 53(633):840-4. PubMed ID: 7437703 [TBL] [Abstract][Full Text] [Related]
19. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium. Shaw DD; Bach-Gansmo T; Dahlstrom K Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616 [TBL] [Abstract][Full Text] [Related]
20. [Usefulness and adverse effects of intrathecal metrizamide instillation (author's transl)]. Masuzawa H; Shimizu H; Sano K No To Shinkei; 1979 Aug; 31(8):843-54. PubMed ID: 315237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]